LifeStance Health Group, Inc. (LFST)
NASDAQ: LFST · IEX Real-Time Price · USD
6.17
+0.06 (0.98%)
At close: Apr 24, 2024, 4:00 PM
6.20
+0.03 (0.49%)
After-hours: Apr 24, 2024, 7:23 PM EDT
LifeStance Health Group Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for LFST stock have an average target of 9.00, with a low estimate of 8.00 and a high estimate of 10. The average target predicts an increase of 45.87% from the current stock price of 6.17.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for LFST stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Reiterates $10 | Buy | Reiterates | $10 | +62.07% | Apr 22, 2024 |
| Jefferies | Jefferies | Strong Buy Maintains $8 → $9 | Strong Buy | Maintains | $8 → $9 | +45.87% | Mar 6, 2024 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $8 → $9 | Hold | Maintains | $8 → $9 | +45.87% | Mar 4, 2024 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $9 → $8 | Hold | Maintains | $9 → $8 | +29.66% | Nov 22, 2023 |
| JP Morgan | JP Morgan | Hold Maintains $10 → $8 | Hold | Maintains | $10 → $8 | +29.66% | Nov 17, 2023 |
Financial Forecast
Revenue This Year
1.25B
from 1.06B
Increased by 17.94%
Revenue Next Year
1.41B
from 1.25B
Increased by 13.09%
EPS This Year
-0.28
from -0.51
EPS Next Year
-0.22
from -0.28
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 1.3B | 1.5B | 1.7B |
| Avg | 1.2B | 1.4B | 1.6B |
| Low | 1.2B | 1.3B | 1.5B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 23.5% | 20.6% | 18.2% |
| Avg | 17.9% | 13.1% | 12.4% |
| Low | 12.4% | 4.7% | 5.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.24 | -0.16 | -0.07 |
| Avg | -0.28 | -0.22 | -0.16 |
| Low | -0.31 | -0.27 | -0.21 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.